Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study

Background: Elabela, a novel cardiac developmental peptide, has been shown to improve heart dysfunction. However, the roles and correlation of Elabela in predicting adverse cardiac events in hypertensive patients with heart failure (HF) remain largely unclear. Objective: To measure plasma levels of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Cardiovasc Med
Egile Nagusiak: Ma, Zheng, Zhao, Lei, Martin, Sara, Zhang, Yeping, Dong, Ying, Zhong, Jiu-Chang, Yang, Xin-Chun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Cardiovascular Medicine
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960768/
https://ncbi.nlm.nih.gov/pubmed/33738301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.638468
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak